Polyethylene glycol mono (4-tert-octylphenyl) ether
Polyethylene glycol mono (4-tert-octylphenyl) ether is a non-denaturing detergent that solubilizes lipid membranes. Polyethylene glycol mono (4-tert-octylphenyl) ether is commonly used in laboratories and is applied to vaccines at different stages of the manufacturing process. Polyethylene glycol mono (4-tert-octylphenyl) ether is listed as an excipient in certain vaccines including split virus influenza vaccines. Polyethylene glycol mono (4-tert-octylphenyl) ether is a nonionic surfactant. Polyethylene glycol mono (4-tert-octylphenyl) ether induces Apoptosis in prostate and colon cancer cell lines and reduces the infectivity of classic enveloped viruses such as WNV[1][2][3][4][5].
Product Specifications
CAS Number
[9002-93-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H318, H410
Target
Apoptosis; Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Apoptosis; Others
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/triton-x-100.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : ≥ 200 mg/mL
Smiles
CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1.[n]
Precautions
H302, H315, H318, H410
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Badge
Hot
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
STn Specific Recomb™ Antibody (V3S-0324-FY70), Mouse IgG2b kappa
